Role of selenium in HIV infection
- PMID: 20961297
- PMCID: PMC3066516
- DOI: 10.1111/j.1753-4887.2010.00337.x
Role of selenium in HIV infection
Abstract
HIV infection is a global disease that disproportionately burdens populations with nutritional vulnerabilities. Laboratory experiments have shown that selenium has an inhibitory effect on HIV in vitro through antioxidant effects of glutathione peroxidase and other selenoproteins. Numerous studies have reported low selenium status in HIV-infected individuals, and serum selenium concentration declines with disease progression. Some cohort studies have shown an association between selenium deficiency and progression to AIDS or mortality. In several randomized controlled trials, selenium supplementation has reduced hospitalizations and diarrheal morbidity, and improved CD4(+) cell counts, but the evidence remains mixed. Additional trials are recommended to study the effect of selenium supplementation on opportunistic infections, and other HIV disease-related comorbidities in the context of highly active antiretroviral therapy in both developing and developed countries.
© 2010 International Life Sciences Institute.
Similar articles
-
The effect of selenium and zinc on CD4(+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial.Acta Clin Belg. 2020 Jun;75(3):170-176. doi: 10.1080/17843286.2019.1590023. Epub 2019 Mar 19. Acta Clin Belg. 2020. PMID: 30888253 Clinical Trial.
-
Micronutrient supplementation in adults with HIV infection.Cochrane Database Syst Rev. 2017 May 18;5(5):CD003650. doi: 10.1002/14651858.CD003650.pub4. Cochrane Database Syst Rev. 2017. PMID: 28518221 Free PMC article. Review.
-
Effect of selenium supplementation on CD4 T-cell recovery, viral suppression, morbidity and quality of life of HIV-infected patients in Rwanda: study protocol for a randomized controlled trial.Trials. 2011 Aug 13;12:192. doi: 10.1186/1745-6215-12-192. Trials. 2011. PMID: 21838913 Free PMC article. Clinical Trial.
-
Selenium supplementation in HIV-infected patients: is there any potential clinical benefit?J Assoc Nurses AIDS Care. 2009 Jul-Aug;20(4):326-33. doi: 10.1016/j.jana.2009.03.006. J Assoc Nurses AIDS Care. 2009. PMID: 19576549 Review.
-
Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy.J Acquir Immune Defic Syndr. 2002 Feb 1;29(2):169-73. doi: 10.1097/00042560-200202010-00010. J Acquir Immune Defic Syndr. 2002. PMID: 11832687
Cited by
-
Selenium Status of Southern Africa.Nutrients. 2024 Mar 27;16(7):975. doi: 10.3390/nu16070975. Nutrients. 2024. PMID: 38613007 Free PMC article. Review.
-
The Role of the Trace Element Selenium in Inflammatory Bowel Disease.Biol Trace Elem Res. 2024 Feb 16. doi: 10.1007/s12011-024-04074-y. Online ahead of print. Biol Trace Elem Res. 2024. PMID: 38363489 Review.
-
Targeted Application of Functional Foods as Immune Fitness Boosters in the Defense against Viral Infection.Nutrients. 2023 Jul 28;15(15):3371. doi: 10.3390/nu15153371. Nutrients. 2023. PMID: 37571308 Free PMC article. Review.
-
Comparative Assessment of Serum Selenium Status in HIV-Infected and Non-infected Children: A Pilot Study in a Tertiary Hospital in Nigeria.Cureus. 2023 May 29;15(5):e39626. doi: 10.7759/cureus.39626. eCollection 2023 May. Cureus. 2023. PMID: 37388617 Free PMC article.
-
SARS-CoV-2 Main Protease Targets Host Selenoproteins and Glutathione Biosynthesis for Knockdown via Proteolysis, Potentially Disrupting the Thioredoxin and Glutaredoxin Redox Cycles.Antioxidants (Basel). 2023 Feb 23;12(3):559. doi: 10.3390/antiox12030559. Antioxidants (Basel). 2023. PMID: 36978807 Free PMC article.
References
-
- UNAIDS . Report on the global AIDS epidemic. UNAIDS; Geneva: 2008.
-
- Fawzi WW, Msamanga GI, Spiegelman D, et al. A randomized trial of multivitamin supplements and HIV disease progression and mortality. N Engl J Med. 2004 July 1;351(1):23–32. 2004. - PubMed
-
- Sappey C, Legrand-Poels S, Best-Belpomme M, Favier A, Rentier B, Piette J. Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Hum Retroviruses. 1994;10(11):1451–1461. - PubMed
-
- Diamond AM, Hu JY, Mansur DB. Glutathione peroxidase and viral replication: Implications for viral evolution and chemoprevention. Biofactors. 2001;14:205–210. - PubMed
-
- Sandstrom PA, Murray J, Folks TM, Diamond AM. Antioxidant Defenses influence HIV-1 replication and associated cytopathic effects. Free Rad Biol Med. 1998;24:1485–1491. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials